- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01099475
Effect of Intermittent Pedicle Clamping on Hepatocellular Injury During Liver Surgery
Randomized Controlled Trial on the Effect of Intermittent Pedicle Clamping Using 15 or 30 Minutes Ischemic Intervals During Liver Surgery
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Surgical procedure Patients were anaesthetized using isoflurane and propofol. They routinely had an epidural catheter, urinary catheter, two peripheral venous catheters and indwelling catheters in a jugular vein and radial artery. Body temperature was maintained using a Bair Hugger system (Arizant Healthcare Inc. Eden Prairie, Minnesota).
The surgical procedure was performed using a subcostal bilateral incision and Olivier retractors to improve exposure. After dissection of the teres hepatis ligament, the liver was mobilized. Thereafter, an intra-operative ultrasound was performed to define the position of the tumour in relation to vascular and biliary structures. As IPM was not routinely applied, a patient was randomized for 15 minted IPM (15IPM) or 30 minutes IPM (30IPM) only after the surgeon had decided a complete Pringle manoeuvre would be required. During 15IPM or 30IPM, the complete portal triad was clamped using a rubber sling. The time of inflow occlusion was adapted to the need according to the randomization protocol. Occasionally, the left or right pedicle was ligated after protocolled IPM. Five minutes reperfusion intervals were applied during which transection was stopped and cut surfaces were gently compressed to ensure hemostasis. A Cavitron Ultrasonic Surgical Aspirator (CUSA system 200 macrodissector, Cavitron Surgical Systems, Stamford, Connecticut) and Argon beam coagulation (Force GSU System, Valleylab, Boulder, Colorado) were used for liver transection. A stapler device or clamps were used for transection of the hepatic veins. Central venous pressure was maintained below 5 centimetre of water (cm H2O) during transection to reduce venous back-bleeding. After surgery, the weight of the resection specimen was recorded. Perioperative care was protocolled, as described earlier.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
PO Box 5800
-
Maastricht, PO Box 5800, Netherlands, 6202 AZ
- Maastricht University Medical Centre
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- patients > 18 years of age and < 100 years of age
- primary or secondary liver tumours requiring liver surgery
Exclusion Criteria:
- pre-existent liver disease (e.g. inflammatory liver disease, cirrhosis, inborn errors of metabolism)
- cholangiocarcinoma requiring biliary tract reconstruction during surgery
- steroid hormone medication
- tumours deemed irresectable during liver surgery
- laparoscopic liver surgery
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Pringle manoeuvre 15 minutes
When intermittent pedicle occlusion during parenchymal transection is necessary, 2 cycles of 15 minutes of hepatic inflow occlusion will be applied each followed by 5 minutes of reperfusion.
During inflow occlusion, the complete portal triad was clamped using a rubber sling.
|
During parenchymal transection, the hepatoduodenal ligament will be clamped by a rubber band for 2-times 15 minutes with 5 minutes reperfusion
|
|
Experimental: Pringle manoeuvre 30 minutes
When intermittent pedicle occlusion during parenchymal transection is necessary, 1 cycle of 30 minutes of hepatic inflow occlusion will be applied followed by 5 minutes of reperfusion.
During inflow occlusion, the complete portal triad was clamped using a rubber sling.
|
During parenchymal transection, the hepatoduodenal ligament will be clamped by a rubber band for 30 minutes with 5 minutes reperfusion
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hepatocellular Damage Reflected by Liver Fatty-acid Binding Protein (L-FABP) Levels
Time Frame: L-FABP area under curve from start of surgery up until postoperative day 3
|
At specific time points before, during and after liver surgery, plasma samples will be obtained to analyse the amount of hepatocellular damage reflected by L-FABP) level.
These timepoints include: baseline (before operation), just before intermittent pedicle clamping, just before end of 15 or 30 minutes pedicle clamping, end of 5 minutes reperfusion, end of liver surgery, 8 hours after start liver surgery, postoperative day 1, 2 and 3.
This continuous variable with repeated measurements was summarized as area under the curve (AUC) from baseline to postoperative day 3 (as described in Matthews JN, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research.
Bmj 1990;300:230-5).
|
L-FABP area under curve from start of surgery up until postoperative day 3
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Post-resectional Complications
Time Frame: within 90-days after initial liver surgery
|
morbidity and mortality occuring after liver surgery graded according to Clavien-Dindo's grading system.
In short, any deviation from the postoperative course without the need for pharmacological, radiological or surgical intervention was classified as Clavien-Dindo grade 1; complications requiring pharmacological treatment were graded as grade 2; complications requiring surgical or radiological intervention not under general anesthesia as grade 3a and under general anesthesia as grade 3b; grade 4 complications were life-threatening complications requiring intensive care unit care because of single organ dysfunction (grade 4a) or multiple organ dysfunction (grade 4b); mortality was classed as grade 5.
|
within 90-days after initial liver surgery
|
|
Amount of Blood Loss
Time Frame: at the end of liver surgery, an average of 225 minutes
|
amount of blood in the suction container (and, if applicable, in the weighted gauzes)
|
at the end of liver surgery, an average of 225 minutes
|
|
Hepatocellular Damage Reflected by Alanine Aminotransferase (ALAT) Levels
Time Frame: ALAT area under curve from start of surgery up until postoperative day 3
|
At specific time points before, during and after liver surgery, plasma samples will be obtained to analyse the amount of hepatocellular damage reflected by ALAT level.
These timepoints include: baseline (before operation), just before intermittent pedicle clamping, just before end of 15 or 30 minutes pedicle clamping, end of 5 minutes reperfusion, end of liver surgery, 8 hours after start liver surgery, postoperative day 1, 2 and 3.
|
ALAT area under curve from start of surgery up until postoperative day 3
|
Collaborators and Investigators
Investigators
- Principal Investigator: Cornelis HC Dejong, MD, PhD, Maastricht University Medical Centre
Publications and helpful links
General Publications
- van den Broek MA, Bloemen JG, Dello SA, van de Poll MC, Olde Damink SW, Dejong CH. Randomized controlled trial analyzing the effect of 15 or 30 min intermittent Pringle maneuver on hepatocellular damage during liver surgery. J Hepatol. 2011 Aug;55(2):337-45. doi: 10.1016/j.jhep.2010.11.024. Epub 2010 Dec 13.
- Dello SA, Reisinger KW, van Dam RM, Bemelmans MH, van Kuppevelt TH, van den Broek MA, Olde Damink SW, Poeze M, Buurman WA, Dejong CH. Total intermittent Pringle maneuver during liver resection can induce intestinal epithelial cell damage and endotoxemia. PLoS One. 2012;7(1):e30539. doi: 10.1371/journal.pone.0030539. Epub 2012 Jan 24.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 06-2-067
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Blood Loss
-
The University of Texas Health Science Center at...CompletedMyomectomy; Surgical Blood LossUnited States
-
Assiut UniversityCompletedHepatectomy, Surgical Blood Loss, TerlipressinEgypt
-
CSL BehringCompletedSurgical Blood Loss | Postoperative Blood LossUnited Kingdom, Canada, Japan, Italy, Poland, Germany, Czech Republic, Austria, Brazil, Denmark, Finland
-
Population Health Research InstituteCompletedBleeding | Surgical Blood LossCanada
-
Northwell HealthCompletedSurgical Blood LossUnited States
-
i-SEPCompletedHemorrhage | Blood Loss | Surgical Blood LossFrance
-
Henry Ford Health SystemCompletedBlood Loss, Surgical | Blood Loss AnemiaUnited States
-
Kasr El Aini HospitalRecruitingTo Calculate Total Blood Loss Immediately PostoperativeEgypt
-
Hamilton Health Sciences CorporationNot yet recruitingBleeding | Seizures | Surgical Blood LossCanada
-
Population Health Research InstituteTerminatedBleeding | Seizures | Surgical Blood LossNew Zealand, Canada, China, Malaysia, Czechia, Russian Federation
Clinical Trials on Pringle manoeuvre 15 minutes
-
Southwest Hospital, ChinaFudan University; Chinese PLA General Hospital; First Affiliated Hospital, Sun... and other collaboratorsCompletedHepatocellular CarcinomaChina
-
General Committee of Teaching Hospitals and Institutes...King Saud UniversityCompletedMuscle Weakness Condition | Hand GraspSaudi Arabia
-
University of ZurichCompleted
-
University of ZurichRecruiting
-
University of ZurichCompleted
-
University of ZurichCompletedChronic Obstructive Pulmonary DiseaseSwitzerland
-
Bayero University Kano, NigeriaCompletedStroke | Hemiparesis;Poststroke/CVANigeria
-
Chang Gung Memorial HospitalRecruiting
-
Lionel BouvetCompleted
-
Medical University of South CarolinaCompleted